Hate to say it Thermo, but that is pretty much what my gut has been saying to me since the AMF thing made me so acutely aware of the total lack of business acumen held by current management (i.e. Andrew and his assistant Martel).
I do not know of contract expiration and possible continuation clauses, but performance clauses could get triggered, with the costs ahead and only 760 million shares to dilute with at penny prices, with some sizable cap ex ahead for test units and testers/tests, plus final engineering independent confirmations.
JMO